A/S Novo Insider Trading $CRVS Corvus Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for A/S Novo.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of A/S Novo. A/S Novo is 10% Owner in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and 10% Owner in BIOMIMETIC THERAPEUTICS, INC. ($BMTI) and 10% Owner in Apollo Endosurgery, Inc. ($LPTN) and 10% Owner in Inogen Inc ($INGN) and 10% Owner in Tobira Therapeutics, Inc. ($TBRA) and 10% Owner in KalVista Pharmaceuticals, Inc. ($KALV) and 10% Owner in CoLucid Pharmaceuticals, Inc. ($CLCD) and 10% Owner in REATA PHARMACEUTICALS INC ($RETA) and 10% Owner in ANAPTYSBIO INC ($ANAB) and 10% Owner in iRhythm Technologies, Inc. ($IRTC) and 10% Owner in Milestone Pharmaceuticals Inc. ($MIST) and 10% Owner in Ophthotech Corp. ($OPHT) and 10% Owner in Flexion Therapeutics Inc ($FLXN) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Bolt Biotherapeutics, Inc. ($BOLT) and 10% Owner in Checkmate Pharmaceuticals, Inc. ($CMPI) and 10% Owner in Morphic Holding, Inc. ($MORF) and 10% Owner in Praxis Precision Medicines, Inc. ($PRAX) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in Eargo, Inc. ($EAR) and 10% Owner in Reneo Pharmaceuticals, Inc. ($RPHM) and 10% Owner in Entasis Therapeutics Holdings Inc. ($ETTX) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in SPRUCE BIOSCIENCES, INC. ($SPRB) and 10% Owner in Harmony Biosciences Holdings, Inc. ($HRMY).

A/S Novo in Corvus Pharmaceuticals, Inc.

Trading Symbol: CRVS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of A/S Novo: 10% Owner
Holdings: 2,130,938 shares
Current Value: $29,470,873
Latest Transaction: Jul 09 2020
$CRVS Market Capitalization: $293.59M
$CRVS Previous Close: $13.83

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of A/S Novo in Corvus Pharmaceuticals, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALGS, ANAB, LPTN, BMTI, BOLT, CMPI, CLCD, CRVS, EAR, EWTX, ETTX, FLXN, GRTX, HRMY, HTGM, INGN, INZY, IRTC, OPHT, KALV, MIST, MIRM, MORF, NKTX, PRAX, RARX, RETA, RPHM, SPRB, TBRA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 09 2020CRVSCorvus Pharmaceuti ...Novo Holdings A/S10% OwnerSellS5.37741,4403,985,1661,389,4982.1 M to 1.4 M (-34.79 %)
Jul 09 2020CRVSCorvus Pharmaceuti ...Novo Holdings A/S10% OwnerSellS5.25796,6224,183,3812,130,9382.9 M to 2.1 M (-27.21 %)
Jul 25 2019CRVSCorvus Pharmaceuti ...Novo Holdings A/S10% OwnerSellS4.001,400,0005,600,0002,927,5604.3 M to 2.9 M (-32.35 %)
Jul 25 2019CRVSCorvus Pharmaceuti ...Novo Holdings A/S10% OwnerSellS5.0153,240266,7114,327,5604.4 M to 4.3 M (-1.22 %)
Jul 25 2019CRVSCorvus Pharmaceuti ...Novo Holdings A/S10% OwnerSellS5.3239,716211,1344,380,8004.4 M to 4.4 M (-0.90 %)
Mar 13 2018CRVSCorvus Pharmaceuti ...Novo Holdings A/S10% OwnerBuyP8.501,176,4709,999,9954,420,5163.2 M to 4.4 M (+36.27 %)
Jun 27 2017CRVSCorvus Pharmaceuti ...Novo Holdings A/S10% OwnerBuyP10.9520,000219,0003,244,0463.2 M to 3.2 M (+0.62 %)
May 16 2016CRVSCorvus Pharmaceuti ...Novo A/S10% OwnerBuyP10.0070,000700,0003,224,0463.2 M to 3.2 M (+2.22 %)
Mar 30 2016CRVSCorvus Pharmaceuti ...Novo A/S10% OwnerOption ExerciseC0.00356,88800
Mar 30 2016CRVSCorvus Pharmaceuti ...Novo A/S10% OwnerOption ExerciseC0.002,130,49200
Mar 30 2016CRVSCorvus Pharmaceuti ...Novo A/S10% OwnerBuyP15.00666,6669,999,9903,154,0462.5 M to 3.2 M (+26.80 %)
Mar 30 2016CRVSCorvus Pharmaceuti ...Novo A/S10% OwnerBuyC0.00356,88802,487,3802.1 M to 2.5 M (+16.75 %)
Mar 30 2016CRVSCorvus Pharmaceuti ...Novo A/S10% OwnerBuyC0.002,130,49202,130,4920 to 2.1 M

Page:   1